http://www.biotechblog.com/2008/05/11/dyadic-founder-fights-to-regain-control-of-company/ Commercial, legal, political, and scientific trends in biotechnology Thu, 09 Feb 2012 15:32:22 +0000 hourly 1 http://wordpress.org/?v=3.3 http://www.biotechblog.com/2008/05/11/dyadic-founder-fights-to-regain-control-of-company/comment-page-1/#comment-9971 Bad boards of directors kill more companies than bad management… | Biotech Blog Fri, 29 Oct 2010 02:48:44 +0000 http://www.biotechblog.com/?p=600#comment-9971 [...] executives, and can be held liable if they don’t do their jobs. As seen in the case of Dyadic, boards of directors can exert great control over companies.I’ve regularly give talks on [...] [...] executives, and can be held liable if they don’t do their jobs. As seen in the case of Dyadic, boards of directors can exert great control over companies.I’ve regularly give talks on [...]

]]> http://www.biotechblog.com/2008/05/11/dyadic-founder-fights-to-regain-control-of-company/comment-page-1/#comment-6016 smaranya.com » Blog Archive » Dyadic founder regains control Tue, 01 Jul 2008 10:23:09 +0000 http://www.biotechblog.com/?p=600#comment-6016 [...] an extended struggle Mark Emalfarb, the founder of Dyadic has regained control of the firm. He was originally ousted by [...] [...] an extended struggle Mark Emalfarb, the founder of Dyadic has regained control of the firm. He was originally ousted by [...]

]]> http://www.biotechblog.com/2008/05/11/dyadic-founder-fights-to-regain-control-of-company/comment-page-1/#comment-6015 Biotech Blog | Dyadic founder regains control Mon, 30 Jun 2008 13:07:58 +0000 http://www.biotechblog.com/?p=600#comment-6015 [...] an extended struggle Mark Emalfarb, the founder of Dyadic has regained control of the firm. He was originally ousted by [...] [...] an extended struggle Mark Emalfarb, the founder of Dyadic has regained control of the firm. He was originally ousted by [...]

]]> http://www.biotechblog.com/2008/05/11/dyadic-founder-fights-to-regain-control-of-company/comment-page-1/#comment-5954 Mac Sun, 01 Jun 2008 18:51:29 +0000 http://www.biotechblog.com/?p=600#comment-5954 I think in this case the one who lost the most is the former CEO Mark Emalfarb, because his dignity was in the stake. He was asked to voluntary resign from its board and was found acused of concealing facts. I think in this case the one who lost the most is the former CEO Mark Emalfarb, because his dignity was in the stake. He was asked to voluntary resign from its board and was found acused of concealing facts.

]]>